Beijing Wehand-Bio Pharmaceutical Co., Ltd
2 clinical trials · Sponsor
◉ Watch Beijing Wehand-Bio Pharmaceutical Co., Ltd
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant Chemotherapy With WH002 in Women With HER2-negative Breast Cancer (NCT06513364) | Beijing Wehand-Bio Pharmaceutical Co., Ltd | 2024-09-10 |
| the Safety, Tolerability and Pharmacokinetics of Mulberry Twig Alkaloids in Human (NCT06490263) | Beijing Wehand-Bio Pharmaceutical Co., Ltd | 2024-05-13 |
Track Beijing Wehand-Bio Pharmaceutical Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.